Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Human Umbilical Cord Secretome Injection for Trophic Ulcers in Leprosy
NCT05777213Phase 1Completed
- Start
- Jan 2019
- Primary completion
- Jan 2022
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Conditioned Medium Wharton's Jelly-derived mesenchymal stem cells in trophic ulcer. Primary endpoints: Changes in Wound Size - Length at 4 weeks, Changes in Wound Size - Width at 4 weeks and 1 more. Started Jan 2019; status: completed.
02
Drugs
Conditioned Medium Wharton's Jelly-derived mesenchymal stem cells
03
Conditions
trophic ulcer
Beyond the preview
Go deeper on NCT05777213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05777213.